Dog Cardiac Disease and Quality of Life Management

Cardiac disease including mitral valve disease and dilated cardiomyopathy affects millions of dogs. Appropriate management extends quality life years and prevents the suffering of unmanaged heart failure.

Key Facts

Mitral valve disease is the most common cardiac disease in dogs, affecting small breeds particularly severely
Cavalier King Charles Spaniels are genetically predisposed to early-onset mitral valve disease
New evidence supports beginning cardiac medication before clinical signs of heart failure appear
Cardiac monitoring every 6-12 months using chest radiography and echocardiography guides treatment decisions
Respiratory rate monitoring at home allows early detection of fluid accumulation before acute crisis
Quality of life in cardiac dogs is significantly affected by exercise tolerance, breathing comfort, and appetite

Welfare Considerations

Cardiac disease welfare management aims to extend the period of comfortable, enjoyable life before the terminal stages of heart failure compromise welfare beyond management. The most significant welfare advance in recent years is the EPIC and QUEST trial evidence supporting pre-symptomatic treatment with pimobendan in dogs with advanced mitral valve disease - delaying the onset of clinical heart failure and extending quality life by an average of 15 months. Home respiratory rate monitoring empowers owners to detect fluid accumulation before acute respiratory distress develops. These interventions together represent meaningful welfare improvements that require owner engagement with monitoring and veterinary partnership with treatment.

What You Can Do

Schedule cardiac examinations for breeds predisposed to cardiac disease from age 5
Ask your vet about pre-symptomatic treatment if your dog has advanced mitral valve disease
Learn to monitor resting respiratory rate at home as an early heart failure detection tool
Maintain a heart-appropriate diet and moderate exercise as cardiac disease progresses
Monitor quality of life using validated scales to guide decisions as disease advances
Consider specialist cardiology referral for diagnosis and management plan in complex cases